PSMD13 polyclonal (C-term), anti-human
€0.00
In stock
SKU
AC-AP2915b
Catalog Number: AC-AP2915b
Size: 80 µl, 400 µl
Isotype: Rabbit IgG
Clone Name: RB21174
Applications: FC, IHC-P, WB
Datasheet
Request Information
Size: 80 µl, 400 µl
Isotype: Rabbit IgG
Clone Name: RB21174
Applications: FC, IHC-P, WB
Datasheet
Request Information
Background:
PSMD13 acts as a regulatory subunit of the 26S proteasome which is involved in the ATP-dependent degradation of ubiquitinated proteins.
Other Names:
26S proteasome non-ATPase regulatory subunit 13, 26S proteasome regulatory subunit RPN9, 26S proteasome regulatory subunit S11, 26S proteasome regulatory subunit p405, PSMD13
Target/Specificity:
This PSMD13 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 269-298 amino acids from the C-terminal region of human PSMD13.
Antigen Region:
269-298
Antigen Type: Synthetic Peptide
Gene Name: PSMD13
Gene ID: 5719
Primary Accession: Q9UNM6
NCBI Accession: NP_002808.3;NP_787128.2
Other Accession: B0BN93; Q9WVJ2; P84169
Format: Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.
PSMD13 acts as a regulatory subunit of the 26S proteasome which is involved in the ATP-dependent degradation of ubiquitinated proteins.
Other Names:
26S proteasome non-ATPase regulatory subunit 13, 26S proteasome regulatory subunit RPN9, 26S proteasome regulatory subunit S11, 26S proteasome regulatory subunit p405, PSMD13
Target/Specificity:
This PSMD13 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 269-298 amino acids from the C-terminal region of human PSMD13.
Antigen Region:
269-298
Antigen Type: Synthetic Peptide
Gene Name: PSMD13
Gene ID: 5719
Primary Accession: Q9UNM6
NCBI Accession: NP_002808.3;NP_787128.2
Other Accession: B0BN93; Q9WVJ2; P84169
Format: Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.
| Is Featured? | No |
|---|
Write Your Own Review